<DOC>
	<DOCNO>NCT01708122</DOCNO>
	<brief_summary>The purpose study assess efficacy intranasally-administrated fentanyl spray decrease pain cystoscopy ( passage telescopic instrument bladder purpose diagnose cause blood urine , urinary complaint problem urinary bladder ) . The current standard practice use Lidocaine jelly ( local anesthetic ) give urethra lubricate decrease pain . In study , additional medicine ( fentanyl ) use reduce pain occurs procedure .</brief_summary>
	<brief_title>Intranasal Fentanyl Analgesic Cystoscopic Procedures</brief_title>
	<detailed_description>In double-blind study , nasal spray either drug ( fentanyl -- opioid analgesic ) placebo ( normal saline ) administer procedure . There 50 % chance patient receive drug placebo . In either case , local Lidocaine jelly use anesthetic urethra . Each patient compensate time travel completion his/her participation . Patients ask arrive 7 11 PM even prior procedure overnight admission 5 East ward , 5th floor Harbor UCLA Medical Center Torrance , California , United States . Once , vital sign ( blood pressure , pulse , oxygen saturation -- amount oxygen blood , breathe rate ) check intravenous line place . Before , procedure , patient ask rate pain scale 0 10 0 `` pain '' 10 `` bad pain possible . '' Regardless whether patient assign receive fentanyl placebo , receive standard care cystoscopic procedure . Once cystoscopy room , patient receive study drug nasal ( nose ) spray . The study drug supply pre-filled syringe contain either 100 mcg fentanyl placebo ( normal saline active medicine ) . Once study drug give , vital sign closely monitor ( check ) effect drug wear , usually 2 4 hour . Blood sample draw several occasion . This blood use see much study drug ( fentanyl placebo ) appear blood . Adverse effect : The well-known adverse effect opioids may occur nasal well conventional route administration ; however , severe adverse effect respiratory depression hypotension seem occur appreciable frequency . Intranasal fentanyl use safely effectively many study . There report serious side effect small dose ( 100 mcg ) use study . Intranasal fentanyl generally well tolerate serious adverse event . In cancer patient treat breakthrough pain , main treatment related side effect nausea , vertigo , dizziness , constipation , somnolence . For local side effect , fentanyl display little local irritation , nasal discomfort taste experience . Nasal irritation , skin pain , nasal mucosa ulcer dysgeusia occasionally report minor side effect . The following minor side effect report form fentanyl ( oral , patch intravenous ) : anxiety ; confusion ; difficulty walking ; dizziness ; drowsiness ; dry mouth ; headache ; itching ; nausea vomit . The follow severe side effect report intranasal fentanyl report form fentanyl ( oral , patch intravenous ) : allergic reaction ( rash ; hive ; difficulty breathing ; tightness chest ; swell mouth , face , lip , tongue ) ; excessive dizziness ; excessive drowsiness ; fainting ; fatigue ; hallucination ; muscle rigidity ; seizure ; shock ( change skin color ) ; slow heartbeat ; respiratory depression slow breathing ; trouble breathe feel weakness . Advantages patient : If effective , less pain cystoscopic procedure well tolerance procedure . Advantages humanity : If effective , nasal fentanyl could use mean reduce pain cystoscopic procedure . These benefit may happen unexpected side effect may develop .</detailed_description>
	<mesh_term>Fentanyl</mesh_term>
	<mesh_term>Analgesics</mesh_term>
	<criteria>1 . Urological indication cystoscopic procedure . 1 . History analgesia abuse former opioid addiction . 2 . Allergy fentanyl . 3 . Acute/chronic nasal problem rhinitis sinusitis . 4 . Positive urine pregnancy test / lactation . 5 . Acute bronchial asthma / upper airway obstruction . 6 . Presence bradycardia history seizure . 7 . Concomitant use drug inhibit CYP3A4 ( e.g. , ritonavir , ketoconazole , itraconazole , troleandomycin , clarithromycin , nelfinavir , nefazodone , amprenavir , aprepitant , diltiazem , erythromycin , fluconazole , fosamprenavir , MAO inhibitor verapamil ) 8 . 010 NRS pain score 3 baseline . 9 . Any situation condition , investigator 's opinion , put subject significant risk , could confound study result .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Intranasal fentanyl</keyword>
	<keyword>Cystoscopy</keyword>
</DOC>